Insights into immune cell lineage identity

By
Mark Wanner

The immune system is comprised of many different types of cells that work together to orchestrate an effective defense against pathogens. One class of immune cells, innate lymphoid cells (ILCs), were only recently described, but they have been shown to be vital for the initiation of protective immune responses. The mechanisms underlying their development and differentiation from common lymphoid progenitor cells (CLPs) in the bone marrow remain unknown, however.

CLPs differentiate into three groups of ILCs (ILC1, ILC2 and ILC3) as well as adaptive lymphocytes, better known as B and T cells. It was previously shown that the lineage fate of CLPs — differentiating into innate (ILC) or adaptive (T or B) lymphocytes — was determined by the Inhibitor of DNA Binding 2 gene (Id2), which, when expressed, inhibits T and B cell development and in favor of ILCs. But differences between the three ILC subsets remained unclear.

Through a complex series of steps, the Rroid locus specifically regulates chromatin accessibility and transcription factor binding at the Id2 promoter. Without the Rroid locus, progenitor cells were able to commit to ILC1 lineage, but later development and maturation of ILC1 group cells was blocked. This indicates that maintenance of lineage identity in ILC populations is controlled by specific epigenetic regulatory elements at the Id2 locus, with Rroid playing a vital role in ILC1 function.